CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing awareness about fertility testing
4.1.2. Declining fertility rates across the globe
4.1.3. The launch of easy-to-use fertility monitors with high accuracy.
4.1.4. Increasing first-time pregnancy age
4.2. Market Restraints & Challenges
4.2.1. The lesser precision of ovulation prediction kits
4.2.2. The unproven accuracy of urine-based ovulation monitors
4.3. Market Opportunities
4.3.1. Emerging nations to offer new growth avenues
4.3.2. The emergence of combined kits for dual testing of pregnancy and ovulation
CHAPTER 5. GLOBAL FERTILITY TEST MARKET – BY PRODUCT
5.1. Ovulation Predictor Kits
5.2. Fertility Monitors
5.2.1 Urine-Based Monitors
5.2.2 Saliva-Based Monitors
5.2.3 Other Fertility Monitors
5.3. Male Fertility Testing Products
CHAPTER 6. GLOBAL FERTILITY TEST MARKET – BY MODE OF PURCHASE
6.1. Non-Prescription/OTC-Based
6.2. Prescription-Based
CHAPTER 7. GLOBAL FERTILITY TEST MARKET – BY APPLICATION
7.1. Female Fertility Testing
7.2. Male Fertility Testing
CHAPTER 8. GLOBAL FERTILITY TEST MARKET – BY END-USER
8.1. Home Care Settings
8.2. Hospitals, Fertility Clinics, & Others
CHAPTER 9. GLOBAL FERTILITY TEST MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL FERTILITY TEST MARKET - COMPANY PROFILES
10.1. Advacare Pharma
10.2 AVA Healthcare Private Ltd.
10.3 Babystart Ltd.
10.4 Biozhena Corporation
10.5 Church & Dwight Co., Inc.
10.6 Fairhaven Health LLC
10.7 Fertility Focus Ltd.
10.8 Geratherm Medical AG
10.9 Hilin Life Products, Inc.
10.10 Prestige Brands Holdings
10.11 Sensiia Ltd.
10.12 Swiss Precision Diagnostics
10.13 Taidoc Technology Corporation
10.14 Uebe Medical GmbH
10.15 Valley Electronics AG
CHAPTER 11. GLOBAL FERTILITY TEST MARKET - COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
